Atom Investors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Atom Investors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.05M	Buy	+16,144	New	+$2.82M	0.22%	153
2021 Q3	–	Sell	-12,093	Closed	-$2.15M	–	346
2021 Q2	$2.15M	Buy	12,093 +6,169	+104%	+$1.07M	0.27%	70
2021 Q1	$974K	Sell	5,924 -31,531	-84%	-$5.19M	0.16%	110
2020 Q4	$6.18M	Sell	37,455 -52,175	-58%	-$7.77M	0.62%	44
2020 Q3	$12.8M	Sell	89,630 -13,614	-13%	-$1.69M	1.22%	17
2020 Q2	$11.4M	Buy	103,244 +68,877	+200%	+$7.62M	0.74%	16
2020 Q1	$3.43M	Buy	+34,367	New	+$4.44M	0.3%	83
2019 Q4	–	Sell	-35,686	Closed	-$4.57M	–	271
2019 Q3	$4.57M	Buy	35,686 +23,871	+202%	+$3.2M	0.31%	105
2019 Q2	$1.68M	Buy	+11,815	New	+$1.59M	0.11%	208

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Atom Investors's JAZZ Position: Q1 2026 in Review

Atom Investors opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 16,144 shares worth $3.05M. The stake represents 0.22% of the portfolio and ranks #153 among its holdings. This is a return to the name: Atom Investors previously reported a position in JAZZ as recently as Q2 2021.

Atom Investors first reported a position in JAZZ in Q2 2019 and has held it in 9 quarters since. The position peaked at $12.8M in Q3 2020. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Atom Investors held 16,144 shares of Jazz Pharmaceuticals worth $3.05M as of Q1 2026.
Jazz Pharmaceuticals was a new Atom Investors position in Q1 2026.
Jazz Pharmaceuticals made up 0.22% of Atom Investors's portfolio in Q1 2026, its #153 holding.
Atom Investors first reported a position in Jazz Pharmaceuticals in Q2 2019 and has held it in 9 quarters since.
Atom Investors's Jazz Pharmaceuticals position peaked at $12.8M in Q3 2020.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.